FOLH1 and neoplasm: Their relatively long half-life enables imaging at later time points post-injection which would allow for higher tumor-to-background ratios compared to images obtained with its gallium-68 (T1/2 = 68 min) counterpart, as demonstrated in a clinical study with [152Tb]Tb-PSMA-617.